Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation - United States
doi 10.1161/circulationaha.110.977546
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Health Care Cost in Patients Undergoing Electrical Cardioversion: An Analysis From the Edoxaban Versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

External Cardioversion in Patients With Persistent Atrial Fibrillation

Japanese Heart Journal
2003English

How to Use Dabigatran in Patients With Atrial Fibrillation

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2012English

Estimating an Icer With NOAC Versus Warfarin in Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Clinical Factors Related to Successful or Unsuccessful Cardioversion in the EdoxabaN Versus Warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) Randomized Trial

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2020English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2013English

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Comparative Effectiveness and Safety of Warfarin and Dabigatran in Patients With Non-Valvular Atrial Fibrillation in Japan: A Claims Database Analysis

Journal of Cardiology
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy